Bioresorbable Vascular Scaffold Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Bioresorbable Vascular Scaffold Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Report Description
Bioresorbable vascular scaffold (BVS) is a nonmetallic mesh tube, which is used to treat blocked arteries. It is similar to a stent but gradually dissolves once the blocked artery starts functioning naturally again, enabling the artery to return to its natural state. The scaffold disappears in around 12-24 months and supports the vessel until it gain its full function. BVS is designed to help open up a blocked artery in the heart and restore blood flow to the heart muscle. It is used by patients who are suffering from different types of cardiovascular diseases. Some of the commonly used BVS for cardiac procedures include Poly-L-Lactide (PLLA) bioresorbable scaffold, metallic bioresorbable scaffold, and hybrid bioresorbable scaffold.
Market Dynamics
Increasing demand for bioresorbable vascular scaffold owing to high prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to drive market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death in the world, accounting for over 17.9 million deaths per year globally, and this number is expected to increase to over 23.6 million by 2030. From the same source, cardiovascular diseases accounted for nearly 836,546 deaths in the U.S. in 2015, which is about 1 of every 3 deaths.
Moreover, key players are opting for different strategies such as new product launches, FDA approvals, partnerships, and collaborations to increase its foothold in the market. For instance, in July 2016, Abbott received the U.S. Food and Drug Administration approval for Absorb bioresorbable heart stent. This device is first-of-its-kind medical device with fully dissolving heart stents. This device will be available to treat people with coronary artery disease in the U.S.
However, preference for vascular graft devices for angioplasty and coronary artery diseases is one of the major factors restraining growth of the global bioresorbable vascular scaffold market. Furthermore, stringent regulatory scenario has also obstructed growth of the market.
Key features of the study:
This report provides in-depth analysis of the bioresorbable vascular scaffold market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles leading players in the global bioresorbable vascular scaffold market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Abbott Laboratories, Cook Medical, Boston Scientific Corporation, Stentys SA, MAQUET Holding B.V. & Co. KG (Getinge AB), W.L. Gore & Associates, Medtronic, C. R. Bard, Inc., B. Braun Melsungen AG, and Terumo Corporation among others
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global bioresorbable vascular scaffold market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for bioresorbable vascular scaffold market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Bioresorbable Vascular Scaffold Market, By Product Type:
Synthetic
Biological
Global Bioresorbable Vascular Scaffold Market, By Material Type:
Metal based BVS
Polymer based BVS
Global Bioresorbable Vascular Scaffold Market, By Application
Coronary Artery Stents
Peripheral Artery Stents
Others
Global Bioresorbable Vascular Scaffold Market, By End User:
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
Others
Global Bioresorbable Vascular Scaffold Market, By Geography:
North America
By Product Type:
Synthetic
Biological
By Material:
Metal based BVS
Polymer based BVS
By Application:
Coronary Artery Stents
Peripheral Artery Stents
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
Others
By Country:
U.S.
Canada
Latin America
By Product Type:
Synthetic
Biological
By Material:
Metal based BVS
Polymer based BVS
By Application:
Coronary Artery Stents
Peripheral Artery Stents
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Synthetic
Biological
By Material:
Metal based BVS
Polymer based BVS
By Application:
Coronary Artery Stents
Peripheral Artery Stents
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Synthetic
Biological
By Material:
Metal based BVS
Polymer based BVS
By Application:
Coronary Artery Stents
Peripheral Artery Stents
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Synthetic
Biological
By Material:
Metal based BVS
Polymer based BVS
By Application:
Coronary Artery Stents
Peripheral Artery Stents
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Synthetic
Biological
By Material:
Metal based BVS
Polymer based BVS
By Application:
Coronary Artery Stents
Peripheral Artery Stents
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Abbott Laboratories*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Cook Medical
Boston Scientific Corporation
B. Braun Melsungen AG
Medtronic Plc
Stentys SA
MAQUET Holding B.V. & Co. KG (Getinge AB)
W.L. Gore & Associates
C. R. Bard, Inc.,
Theragenics Corporation
“*” marked represents similar segmentation in other categories in the respective section.